Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. - Wikidata - awgldk - TriplyDB

Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.

Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.

http://www.wikidata.org/entity/Q44993179

about

Cellular immunotherapy as a beacon of hope for hematological malignancies The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases Recent advance in antigen-specific immunotherapy for acute myeloid leukemia Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission.The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.Current progress in the development of a cell-based vaccine for the immunotherapy of acute myeloid leukemia.Biological response modifiers as adjuncts to stem cell transplantation.Dendritic cell vaccines for leukemia patients.Dendritic cell vaccination.Dendritic cell-based immunotherapy for myeloid leukemias.Combination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experience Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.Vaccines as consolidation therapy for myeloid leukemia.Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.Current strategies in immunotherapy for acute myeloid leukemia.DC-based immunotherapy for hematological malignancies.Spontaneous remission of acute myeloid leukemia.Update on antigen-specific immunotherapy of acute myeloid leukemia.Nonleukemic myeloid dendritic cells obtained from autologous stem cell products elicit antileukemia responses in patients with acute myeloid leukemia.Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells.Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells.Large-scale generation of autologous dendritic cells for immunotherapy in patients with acute myeloid leukemia.Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity.Down-regulation of cellular vascular endothelial growth factor levels induces differentiation of leukemic cells to functional leukemic-dendritic cells in acute myeloid leukemia.

P2860

Q26784288-7E2B9008-2FF8-4779-8BDC-F68C2B0F155C Q26852652-52F6AD81-2118-4882-8AD5-CA97F6C4208E Q27005765-80A1D9C3-C8D6-46BA-AAC4-ADD641BBF992 Q34068404-46F5EC3F-CDE2-4323-A820-38AC1C1FFFCD Q35240847-00D6B0A5-99DA-4962-83BF-3202738D52EC Q35888562-7D26CF10-CC17-40C2-91EA-14BEFE6B17FE Q36445541-C3AD3B87-03F0-438E-AA2B-4EBD09B07DAE Q36446933-6864A2FA-14CF-4009-98BF-3D671AC2AAF1 Q36752018-833D2364-DBEA-4EE0-80A9-A553DBA555E4 Q36899104-269D7D57-CE8F-46D2-AE2E-3EE699C5023F Q37420778-39FD3203-33B2-44D8-BC8C-27339831F880 Q37772085-F2668FDA-E0F1-4433-B9A5-73435CAD2826 Q37773237-CE6CD79E-C295-4CB5-B2B5-7FBF31A680F6 Q37842342-7926EB91-528A-4982-8A39-F414593311E8 Q37868974-7AEAA9C1-A4AB-40F3-BD98-F375ADC5D2B8 Q38068967-A36635B6-2970-4905-891C-72AB66050F23 Q38174828-3FC54CC2-D943-4D2E-A592-0A0AFCE5CCAB Q38256921-B673A116-4FC0-43CD-9EA4-9ABD9677EEA8 Q38432103-5DB1AB7E-5443-4DF1-97A9-5778D5952406 Q39596000-F6D6B048-37AB-45DD-9C16-2C84B1E570B4 Q41844970-5B7F262A-4B11-4E0A-81AC-724AFF5F6ACF Q44607712-E1A96294-AF10-43A6-9F9A-94601FBB2778 Q45789544-E5A646AA-E72A-4483-A42F-7730E29EE076 Q46965111-EA618006-6CE2-4BBC-88BB-92C029E9751F Q53378105-5EEA2F90-CEB8-4C28-9C8E-96F6D64634A3 Q53585655-07A4C1E0-429E-4124-8D68-6A5A7A02B376

P2860

Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.

http://www.wikidata.org/entity/Q44993179

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Immunotherapy using autologous ...... ood stem cell transplantation.

@en

Immunotherapy using autologous ...... ood stem cell transplantation.

@nl

type

label

Immunotherapy using autologous ...... ood stem cell transplantation.

@en

Immunotherapy using autologous ...... ood stem cell transplantation.

@nl

prefLabel

Immunotherapy using autologous ...... ood stem cell transplantation.

@en

Immunotherapy using autologous ...... ood stem cell transplantation.

@nl

P1433

Q44993179-EECCFC0A-2EF5-4BE2-A32E-C13F4A9AA875

P1476

Q44993179-2B14A904-8059-403A-87E2-D31323CDA4A1

P2093

Q44993179-2A3D9D92-8E8F-4E86-8587-BCE4B7FA1F1B

Q44993179-43C9FC02-1580-41E3-AEA8-AED14C540B09

Q44993179-619D530A-5D3C-4E85-8145-2B45DE2E1F60

Q44993179-62F41D19-3829-4B11-B8C0-6B8AFD121E1D

Q44993179-827F4CFE-200A-4D13-9980-33C52305957A

Q44993179-9973DB60-AA5E-4205-995F-7E5059D1B6CA

Q44993179-AFD6AEB5-98EB-4223-A00F-1479522E4919

Q44993179-B2B05644-2DDC-4C41-9790-183F8B01F6A1

Q44993179-D2E0D3A9-8866-4A84-87DD-24382D04E2C3

Q44993179-E076F1CF-4FB2-45D3-9334-B2716CE56020

P304

Q44993179-65291E7C-D99B-46BE-AE53-E4C9E4D83594

P31

Q44993179-5135AD2E-5A10-4CA3-AFD3-D8DE3F925556

P356

Q44993179-F76B33FA-FFB9-4F40-86D5-1B48B9CE3064

P433

Q44993179-94F995AF-3C2E-4142-95F5-A7855355180B

P478

Q44993179-AD41384C-8753-405D-9300-3DBCB38D8E88

P577

Q44993179-4EF42F73-F950-4A87-A581-57FC8638F9DB

P698

Q44993179-8CF36681-FD8F-4146-9BEE-E956C16C6FCE

P921

Q44993179-E4D58F0B-CD51-4685-B1B1-B8D5F39ED37B

Q44993179-FE662149-7E87-4AA2-8038-9A44EF437BA2

P356

P1433

Journal of Clinical Apheresis

P1476

Immunotherapy using autologous ...... ood stem cell transplantation.

@en

P2093

Bo-Hwa Choi

http://www.w3.org/2001/XMLSchema#string

Hoon Kook

http://www.w3.org/2001/XMLSchema#string

Hyeoung-Joon Kim

http://www.w3.org/2001/XMLSchema#string

Ik-Joo Chung

http://www.w3.org/2001/XMLSchema#string

Il-Kwon Lee

http://www.w3.org/2001/XMLSchema#string

Je-Jung Lee

http://www.w3.org/2001/XMLSchema#string

Jong-Hee Nam

http://www.w3.org/2001/XMLSchema#string

Kyeong-Soo Park

http://www.w3.org/2001/XMLSchema#string

Myong-Suk Park

http://www.w3.org/2001/XMLSchema#string

Tai-Ju Hwang

http://www.w3.org/2001/XMLSchema#string

P304

66-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCA.10080

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15274198

http://www.w3.org/2001/XMLSchema#string

P921